CEACAM5 and colorectal carcinoma: Some clinicopathological parameters, such as carcinoembryonic antigen (CEA) and CA19–9, have been used for screening and monitoring CRC26, 27; however, these parameters remain controversial for predicting the prognosis and surveillance of CRC patients.